膜联蛋白AnxB1的同源模建及降低免疫原性研究

膜联蛋白AnxB1是我们发现的一个新的膜联蛋白亚家族成员, 具较强的抗凝血活性和血栓亲和性. 为更深入研究AnxB1的结构与功能, 首先利用同源建模的方法预测AnxB1的三维结构, 发现AnxB1具有四个内部同源结构域, 其中1, 2, 4结构域的Cα主链叠合非常一致. 以此为基础, 构建四个序列缺失突变体M1, M2, M3, M4, 并在大肠杆菌GST融合表达系统表达, 其中的两个突变体GST-M3, GST-M4不仅保留了较强的抗凝血活性, 而且免疫原性大大降低, 分子量也分别减少到27和34 kD. 为进一步构建高效、低免疫原性的靶向性溶栓药物奠定了基础.     

人肽抗生素hPAB—β分子的同源模建及其突变体设计

从人体基因组中克隆了一个编码肽抗生素样的基因。按基因编码产物的氨基酸序列 ,化学合成目的产物 ,经药物敏感测定法证实产物具有杀菌活性。旨在通过同源模建的方法 ,构建肽抗生素hPAB β的突变体分子 ,希望获得肽链更短 ,但生物活性不降低甚至更强的突变体。方法是在序列比较的基础上 ,利用同源分子对目的肽抗生素hPAB β进行同源模建 ,在此模型上 ,删除某些氨基酸后观察目的分子立体结构模型改变情况 ,从而确定突变体分子结构。同源模建结果表明hPAB β由一个α螺旋和 3个 β片层构成 ,二级结构保守 ;具有两亲性结构 ,推测与目的肽进…     

睫状神经营养因子突变体的设计及活性分析

利用计算机分子模拟系统模建了CNTFRα的三维结构,并对CNTF与CNTFRα结合的关键部位进行分析,同时综合了同源比较的结果及CNTF分子自身的特点,设计了2个CNTF的突变体A和B.表达纯化后得到目的蛋白,TF-1细胞增殖实验的结果表明,2个突变体蛋白的比活性均达到106U/mg的水平,且A的活性大于B的活性.上述结果初步表明设计的合理性,为其进一步的开发和应用奠定了基础.     

蓖麻毒素A链突变体的设计和结构模建

蓖麻毒素Ａ链（ＲＴＡ）有抑制蛋白质合成的功能,可用作“生物导弹”的弹头,但其免疫原性较强。我们根据国外所做的ＲＴＡ连续突变的实验结果,以及ＰＤＢ库中ＲＴＡ及其同源蛋白的结构信息,设计了一个ＲＴＡ突变体,缺失的５个片段与功能及结构保守性关系较小。然后,我们用同源模建的方法对设计出的ＲＴＡ突变体进行三维结构模建,初步验证表明模型基本合理     

人凋亡相关基因TFAR19缺失突变体的原核表达、产物纯化及鉴定

构建TF 1细胞凋亡相关基因 19(TF 1cellapoptosisrelatedgene 19,TFAR19)缺失突变体的原核表达载体 ,获取缺失突变体蛋白 ,用于TFAR19促凋亡分子机理的研究 .从真核表达载体pcDI TFAR19扩增出野生型TFAR19和 4个缺失突变体 ,重组到原核表达载体pGEX 4T 2 .经亲和层析方法对缺失体蛋白进行纯化后 ,再利用凝胶过滤的方法进一步纯化 .利用抗GST和抗TFAR19的单克隆抗体对蛋白进行免疫学鉴定 .用白血病细胞株HL 6 0检测蛋白活性 .成功地克隆并重组了野生型TFAR19及缺失突变体 pGEX 4T 2表达载体 ,对融合蛋白的表达条件进行了优化 .SDS PAGE结果显示 ,各个缺失突变体融合蛋白均有较高水平的表达 .免疫学检测证实获得了正确的表达产物 .活性检测证实 ,野生型TFAR19和缺失突变体 4可以明显促进去血清诱导的HL 6 0细胞凋亡 ,第 6外显子可能是一个与TFAR19促凋亡活性密切相关的功能结构域     

蓖麻毒素A链突变体的设计和结构模建

蓖麻毒素Ａ链（ＲＴＡ）有抑制蛋白质合成的功能,可用作“生物导弹”的弹头,但其免疫原性较强。我们根据国外所做的ＲＴＡ连续突变的实验结果,以及ＰＤＢ库中ＲＴＡ及其同源蛋白的结构信息,设计了一个ＲＴＡ突变体,缺失的５个片段与功能及结构保守性关系较小。然后,我们用同源模建的方法对设计出的ＲＴＡ突变体进行三维结构模建,初步验证表明模型基本合理     

低出血倾向、低免疫原性葡激酶mSAK(K130T,K135R)的表达、纯化与活性测定

为了有效降低葡激酶应用的副作用,构建低出血倾向、低免疫原性葡激酶突变体,高效表达纯化后进行活性鉴定,以野生型重组葡激酶基因为模板,PCR法引入突变位点(K130T,K135R),并将该片段克隆测序鉴定后,克隆至表达载体pBV220,构建低免疫原性葡激酶突变体.表达后的蛋白用Q-SepharoseFF柱与SephacrylS-200进行纯化,纤维蛋白溶圈法进行活性测定,体外抗体中和试验与豚鼠免疫试验测定突变体蛋白的免疫原性,同时进行动物体内出血倾向观察.测序结果表明,相应位点获得突变,无非特异性突变,将突变后的片段连接pBV220导入大肠杆菌热激诱导获得了高效表达,表达产物占菌体总蛋白的40%~50%.产物主要以可溶性形式存在,经两步纯化后的蛋白的纯度可达98%以上.活性测定试验表明,该突变体的活性较野生型葡激酶稍低,体外中和抗体试验和豚鼠免疫试验证明免疫原性大为下降,豚鼠的皮肤出血以及肺部病理切片均显示该突变体蛋白引起的出血倾向明显降低.     

小鼠TAp63γ及两种突变体的原核表达、纯化和DNA结合活性

采用PCR扩增法得到小鼠TAp63γ野生型及两种缺失突变体的cDNA,3种cDNA与表达载体pGEX-2TK重组构建成GST融合表达质粒并转化感受态E.coli BL21 (DE3),经IPTG诱导了小鼠TAp63γ野生型及两种缺失突变体的可溶性表达. 诱导表达的菌液经离心收集菌体、超声破碎及Triton X-100增溶后获得可溶性表达蛋白粗提液. 利用Glutathione Sepharose 4 Fast Flow亲合层析纯化出电泳均一的3种GST融合蛋白. 凝胶滞留分析证实仅野生型小鼠TAp63γ蛋白能特异结合p53靶序列,经序列比对及同源建模分析,表明小鼠TAp63γ DBD结合区的完整性、关键氨基酸的保守性及三维结构的相似性可能是其DNA结合活性所必需的.     

重组单链抗体-低分子质量尿激酶融合蛋白在 CHO 细胞中的抗降解研究

抗人纤维蛋白单链抗体-低分子质量尿激酶(Ⅱn-UK)融合蛋白,兼有单链抗体对纤维蛋白的亲和性和尿激酶的溶栓活性,有望开发成为新型导向溶栓药物.但基于通用连接肽(G4S)3的Ⅱn-linker-UK融合蛋白在CHO细胞中表达时出现明显的降解.为了解决此问题,利用分子生物学方法,对Hn-UK融合蛋白进行了分子改造,包括置换连接肽,改变两个半分子(moiety)的相对位置,以及对连接肽附近明确的蛋白酶位点进行突变等方法,并分别研究了改造后的11种Ⅱn-1inker-UK或UK-linker-Ⅱn突变体在CHO细胞中分泌性表达时的稳定性,最终筛选到一种抗降解的突变体.     

拟南芥DNA去甲基化基因RLL4的定位与功能分析

该研究以携带2×35S:LUC报告基因的转基因拟南芥Col-LUC为亲本系,将其种子进行甲基磺酸乙酯(EMS)诱变,在M2代筛选出1株低荧光的候选突变体,命名为rll4(reduced LUC luminescence 4)。遗传学分析表明,rll4突变位点包含1个核基因隐性突变。图位克隆技术定位结果显示,突变基因的位点位于4号染色体2个分子标记CL417-B10M1和CL418-B2M2之间,这2个分子标记分别位于F20D10和F20M13BAC(bacterial artificial chromosome)克隆。酶切PCR(Chop-PCR)结果显示,rll4突变体中基因组DNA的部分位点甲基化显著升高。反转录PCR(RT-PCR)结果显示,rll4突变体中ROS1(REPRESSOR OF SILENCING 1)的表达量并没有明显变化,而一些RNA介导的DNA甲基化(RdDM)过程靶位点的基因表达量有明显下降。研究表明,RLL4位点很可能参与了拟南芥DNA去甲基化过程。     

Homology modeling threedimensional structure of AnxB1 and reducing its immunogenicity by sequence-deleted mutagenesis

AnxB1,a novel annexin previously isolated from Cysticercus cellulose,shows high thrombi affinity and anticoagulant activity in vivo.In order to investigate the relationship between structure and biological function,a predicted three-dimensional(3D)model of AnxB1 was generated by homology modeling.This model contains four homologous internal-domains and the Cα trace of domain Ⅰ,Ⅱ and IV shows high similarity.Based on the structure characterization,four sequence-deleted mutants were constructed and expressed as GST fusion proteins in E.coli.Two of the mutants,GST-M3 and GST-M4 reserved high anticoagulant activity(p＜0.01 vs.GST).Furthermore,compared with the wild type GST-AnxB1,the immunogenicity of GST-M3 and GST-M4 was reduced significantly(p＜0.01)and the molecular weight was lowered to 27 kD and 34 kD,respectively.These observations laid a solid foundation for further study on developing new thrombolytic agents with higher efficiency and lower side effect.     

Homology modeling three-dimensional structure of AnxB1 and reducing its immunogenicity by sequence-deleted mutagenesis

We previously isolated and functionally identified a new annexin from Cysticercus cellulosae, which belongs to a novel annexin subfamily and is desig-nated as AnxB1[1]. In the presence of Ca2+, AnxB1 can bind to negatively charged phospholipids like phos-phatidylserine (PS) with high affinity, whereas hardly associates with phosphatidylcholine (PC) even at high Ca2+ concentration. PS is the major component of the platelet membrane and plays a key role in the process of coagulation cascade.…     

Screening,purification, and identification of annexin B1 mutants with high phosphatidylserine-binding activity and reduced immunogenicity

Annexin B1 has many potential biomedical applications based on its high affinity for negatively charged phospholipid (phosphatidylserine, PS) in the presence of physiological concentrations of calcium. Low immunogenicity is prerequisite for the in vivo application of a nonhuman protein as a novel-imaging agent. In the present study, three sequence-deleted mutants with different numbers of functional domains were designed and expressed according to the predicted three-dimensional structure of annexin B1. The mutants of annexin B1, as well as the wild-type annexin B1, were expressed as Glutathione-S-transferase (GST)-fusion proteins. Two mutants with their purity above 80% could be obtained after one-step primary purification procedure on basis of the PS-binding activity. The immunogenicity of the two mutants was evaluated in mice by detecting the titers of elicited antigen-specific IgG. A member of three mutants of annexin B1, M12, which involved N-terminal amino-acid sequence and double functional domain I and II of annexin B1, was finally selected to detect apoptosis that is due to its lowest immunogenicity among the candidate mutants. Flourescein isothiocyanate-labeled M12 could bind the outer membranes of apoptotic cells and discriminate apoptotic cells in the early stage from necrotic cells when used with propidium iodide. ^99mTc-labeled M12 could recognize the apoptotic hepatocytes induced by anti-Fas antibody treatment. Our data in vitro and in vivo demonstrated that M12 could be applied as a promising agent for the detection of apoptosis.     

Homology modeling of the structure of tobacco acetohydroxy acid synthase and examination of the active site by site-directed mutagenesis

A reliable model of tobacco acetohydroxy acid synthase (AHAS) was obtained by homology modeling based on a yeast AHAS X-ray structure using the Swiss-Model server. Conserved residues at the dimer interface were identified, of which the functional roles of four residues, namely H142, E143, M489, and M542, were determined by site-directed mutagenesis. Eight mutants were successfully generated and purified, five of which (H142T, M489V, M542C, M542I, and M542V) were found to be inactive under various assay conditions. The H142K mutant was moderately altered in all kinetic parameters to a similar extent. In addition, the mutant was more thermo-labile than wild type enzyme. The E143A mutant increased the Km value more than 20-fold while other parameters were not significantly changed. All mutations carried out on residue M542 inactivated the enzyme. Though showing a single band on SDS-PAGE, the M542C mutant lost its native tertiary structure and was aggregated. Except M542C, each of the other mutants showed a secondary structure similar to that of wild type enzyme. Although all the inactive mutants were able to bind FAD, the mutants M489V and M542C showed a very low affinity for FAD. None of the active mutants constructed was strongly resistant to three tested herbicides. Taken together, the results suggest that the residues of H142, E143, M489, and M542 are essential for catalytic activity. Furthermore, it seems that H142 residue is involved in stabilizing the dimer interaction, while E143 residue may be involved in binding with substrate pyruvate. The data from the site-directed mutagenesis imply that the constructed homology model of tobacco AHAS is realistic.     

The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae

Sequencing of the neurofibromatosis gene (NF1) revealed a striking similarity among NF1, yeast IRA proteins, and mammalian GAP (GTPase-activating protein). Using both genetic and biochemical assays, we demonstrate that this homology domain of the NF1 protein interacts with ras proteins. First, expression of this NF1 domain suppressed the heat shock-sensitive phenotype of yeast ira1 and ira2 mutants. Second, this NF1 domain, after purification as a glutathione S-transferase (GST) fusion protein, strongly stimulated the GTPase activity of yeast RAS2 and human H-ras proteins. The GST-NF1 protein, however, did not stimulate the GTPase activity of oncogenic mutant ras proteins, H-rasVal-12 and yeast RAS2Val-19 mutants, or a yeast RAS2 effector mutant. These results establish that this NF1 domain has ras GAP activity similar to that found with IRA2 protein and mammalian GAP, and therefore may also regulate ras function in vivo.     

Construction, expression, and characterization of a recombinant annexin B1-low molecular weight urokinase chimera in Escherichia coli

Thrombolytic therapy has been a major advance in thtreatment of myocardial infarction over the last twdecades. Urokinase (UK), streptokinase (SK), and tissuplasminogen activator (t-PA) are the common availablthrombolytic agents. These agents, however, hav…     

Optimized Heterologous Expression of the Polymorphic Human Glutathione Transferase M1-1 Based on Silent Mutations in the Corresponding cDNA

An expression clone for large-scale production of the polymorphic human glutathione transferase (GST) M1-1 has been developed. Heterologous expression inEscherichia coliafforded a yield of 100 mg of GST M1-1 per 3 liters of culture medium, corresponding to an approximately 10-fold increased yield compared to the parental expression construct. Overproduction of the enzyme was dependent on the codon usage in the 5′ region of the DNA sequence encoding glutathione transferase M1-1. High-level expression clones were generated by a combination of random silent mutations in selected wobble positions in the coding sequence and immunoselection of clones from the library of random mutants. The strategy used is generally applicable for the production of recombinant proteins provided that a suitable selection procedure is available for identifying the desired mutants.     

Cysteine residues are not essential for the catalytic activity of human class Mu glutathione transferase M1a-1a

To investigate the possible involvement of a Cys thiol in the catalysis of the human glutathione transferase M1a-1a, we constructed mutants of this enzyme wherein the four Cys residues present in the native enzyme were replaced by Ala residues. Three mutants, one where all four Cys residues had been replaced and two mutants where three out of four Cys residues were changed into Ala, were characterized regarding their catalytic activities with three different substrates as well as by their binding of three different inhibitors. All three Cys-deficient mutant forms of glutathione transferase M1a-1a were catalytically active with the tested substrates and their binding of inhibitors, measured by I50, were not significantly different from the values previously obtained for the wild-type enzyme. We therefore conclude that none of the Cys residues in this class Mu glutathione transferase are directly involved in the catalysis performed by this enzyme.     

大肠杆菌PGDH末端缺失突变体的构建及抗反馈抑制效应分析

为了获得具有抗反馈抑制性质的大肠杆菌磷酸甘油酸脱氢酶（PGDH, d-3-phosphoglycerate dehydrogenase, EC 1.1.1.95）,通过对其碱基序列和蛋白质结构分析,用PCR突变法构建突变酶M1（缺失第410位氨基酸）、M2（缺失407~410位氨基酸）、M3（缺失337~410位氨基酸）。M0(野生型)及各突变型基因与pET22b(+)载体连接后,表达融合蛋白。在非变性条件下,由NTA-Ni镍离子螯合亲和层析柱纯化野生型和突变体的酶蛋白。酶活性测定结果表明,M1、M2蛋白酶均保持了原有的野生型磷酸甘油酸脱氢酶活性,且部分解除了终产物L-丝氨酸的反馈抑制作用;M3蛋白酶完全解除了终产物的反馈抑制作用,但酶本身的催化活性略有降低（为野生型的83%）。M0、M1、M2菌株PGDH与L-丝氨酸结合的Ki值分别约为7 μmol/L、20 μmol/L、50 μmol/L,说明该酶C-末端1~4个氨基酸残基对L-丝氨酸和调控区的结合有重要影响。     

Csk-homologous kinase interacts with SHPS-1 and enhances neurite outgrowth of PC12 cells

SHPS-1 is an immunoglobulin superfamily protein with four immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in its cytoplasmic region. Various neurotrophic factors induce the tyrosine phosphorylation of SHPS-1 and the association of SHPS-1 with the protein tyrosine phosphatase SHP-2. Using a yeast two-hybrid screen, we identified a protein tyrosine kinase, Csk-homologous kinase (CHK), as an SHPS-1-interacting protein. Immunoprecipitation and pull-down assays using glutathione S -transferase (GST) fusion proteins containing the Src homology 2 (SH2) domain of CHK revealed that CHK associates with tyrosine-phosphorylated SHPS-1 via its SH2 domain. HIS3 assay in a yeast two-hybrid system using the tyrosine-to-phenylalanine mutants of SHPS-1 indicated that the first and second ITIMs of SHPS-1 are required to bind CHK. Over-expression of wild-type CHK, but not a kinase-inactive CHK mutant, enhanced the phosphorylation of SHPS-1 and its subsequent association with SHP-2. CHK phosphorylated each of four tyrosines in the cytoplasmic region of SHPS-1 in vitro . Co-expression of SHPS-1 and CHK enhanced neurite outgrowth in PC12 cells. Thus, CHK phosphorylates and associates with SHPS-1 and is involved in neural differentiation via SHP-2 activation.